Table 2.
Total Cohort (n = 401) |
Metformin Treatment (n = 99) |
No Metformin Treatment (n = 302) |
P Value | |
---|---|---|---|---|
Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, % |
87 | 93 | 85 | .052 |
β-blocker, % | 66 | 86 | 59 | .0001 |
Aldosterone antagonist, % | 44 | 49 | 42 | .245 |
Statin, % | 65 | 74 | 62 | .036 |
Antiarrhythmic, % | 30 | 20 | 34 | .007 |
Insulin, % | 43 | 11 | 53 | .0001 |
Sulfonylurea, % | 49 | 56 | 47 | .151 |
Thiazolidinedione, % | 14 | 24 | 11 | .002 |